Our executive speaking faculty, armed with their field experience, war stories and more, are here to help you demystify the legal IP landscape and strengthen your patenet strategies
REGISTER YOUR INTEREST TODAY AND BE THE FIRST TO SEE THE AGENDA
If you wish to get involved, contact [email protected] for further information
-
Adrian Spillmann
Director of Intellectual PropertyValneva -
Agnieszka Deeg-Tyburska
General CounselPolpharma -
Andrea Andrade
VP PartnershipsRWS -
Andreas Robinson
Senior Counsel Intellectual Property & LitigationAmgen -
Bianca Vos
PartnerHoffmann Eitle -
Cecile Teles
Head of IPZentivaCecile is Head Patent Attorney at Zentiva. She has over a decade of experience in the pharmaceutical industry.
Cecile is uniquely experienced and knowledgeable in the pharma space as she has experience in-house at an elite innovator company (Sanofi), biologics (Merck Serono), and extensive generic experience she gained as Zentiva.
Cecile is an enthusiastic manager of her team and was a key member of the IP team in leading the transformation of Zentiva into an independent and competitive generic company after divestment from Sanofi.
Cecile is a qualified European Patent Attorney. She also holds a certificate from CEIPI in patent litigation and most recently completed her diploma as a Master of Laws in France.
-
Christina Thomson
Managing AssociateSimmons & Simmons -
Christof Bull
Associate General Patent CounselUCB -
Corinna Sundermann
Senior Vice President Intellectual PropertyFresenius Kabi -
Denis Schertenleib
PartnerSchertenleib Avocats -
Dolores Cassidy
Head of Patent/SPC ExaminationIntellectual Property Office of IrelandDolores Cassidy, B.Sc. Ph.D., graduated from University College Dublin with a Ph.D. in Physical Chemistry. In 1998 she joined the Intellectual Property Office of Ireland as a Patent Examiner, with particular responsibility for the examination of Supplementary Protection Certificates (SPCs). In 2021 she was promoted to the position of Head of Patent/SPC Examination at the Irish Office.
-
Dorian Immler
Head of PatentsBayer -
Eva Ehlich
PartnerMaiwald -
Filipe Pedro
Director of IPBIAL -
Ha Kung Wong
Partner, Advisory Board MemberVenable, Centre for BiosimilarsHa Kung Wong has over 20 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions, and collaborations in pharmaceuticals, biologics, and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussive, injectable microspheres, RNAi products, and other pharmaceuticals. Mr. Wong also has extensive experience with Inter Partes Review, Post Grant Review, intellectual property counseling, pharmaceutical regulatory counseling, pre-suit investigations, licensing, and due diligence.
Mr. Wong has his BS with high distinction in Chemistry and his BS in Biochemistry from the University of Illinois Urbana-Champaign and his JD, cum laude, from the University of Notre Dame. Mr. Wong is currently an elected member of the Venable Board, is an Advisory Board Member for the Center for Biosimilars, is Treasurer, Executive Committee member, and Board Trustee for the Foundation for Advancement of Diversity in IP Law (FADIPL) and serves as faculty for the National Institute of Trial Advocacy (NITA) and Lawline.
-
Hilary Pioro
Senior Patent CounselPolpharma Biologics -
Isabelle Gundell
Senior Patent AttorneyHaleon -
Karin Pramberger
Intellectual Property DirectorPolpharma GroupKarin has been Intellectual Property Director at the Polpharma Group since April 2018. She is responsible for all patent and trade mark related activities. Prior to joining the Polpharma Group, Karin was Head of IP of Medichem, Spain, and worked in various positions within the patent department of Teva, Barr and Pliva. She spent 7 years in a law firm in Vienna, Austria, where she became European and Austrian patent and trade mark attorney. She studied Biotechnology in Vienna, Austria, and at the Ecole Nationale Supérieure de Chemie de Paris, France. In 2017 she graduated with an LLB from the University of London. Since 2005 she has been a tutor at CEIPI, University of Strasbourg, for the pre-exam and the C-part of the European Qualifying Exam.
-
Kit Carter
Head of IP LitigationSandoz -
Laila Beynon
AD- Dispute ResolutionRegeneronLaila Beynon is Director, Dispute Resolution at Regeneron, responsible for the strategic co-ordination of ex-US patent litigation. She has a PhD in Biochemistry/Molecular Biology, 10 years’ private practice experience in life sciences patent litigation at Herbert Smith Freehills LLP, and prior to her role at Regeneron headed up the Patent Litigation team at BAT.
-
Marco Stief
PartnerMaiwald -
Margaret O'Gara
Director of IPNanobiotixMargaret is a French and European patent attorney currently heading IP at a late development stage biotech in Paris, called Nanobiotix.
She started her professional career as a researcher in the pharma industry in the UK and France, before moving into patents in 2004.
Since then she has worked both in-house and in IP firms and spent nearly ten years with Santarelli before taking the IP position at Nanobiotix early 2020. Margaret has considerable experience in all aspects of European patent prosecution, and post grant proceedings, as well as strategies for filing new applications . She is interested in data exclusivity and prolonging the protection of innovative products.
-
Christoph Rehfuess
Head of IPSotio -
Dr Martijn de Lange
Patent ExaminerNetherlands Patent Office -
Michal Porubsky
Senior Litigation CounselNovo Nordisk -
Dr Oliver Werner
Head Patent Department, Head SPC Working GroupGerman Patent and Trade Mark Office -
Paul Calvo
DirectorSterne Kessler -
Pedro Roman, IP Counsel, Insud Pharma
IP CounselInsud Pharma -
Rachel Goode
Senior Vice President, Legal and Intellectual Property, BiopharmaceuticalsFresenius Kabi -
Roberto Rodrigues
PartnerLicks AttorneysRob Rodrigues manages high-stakes business and IP disputes in Brazil. He assists Fortune 500 and startup companies in matters requiring complex technical ability with a strategic approach, managing patent portfolios of the largest life sciences companies across the globe. His understanding of the Brazilian market makes him a "go-to" lawyer when dealing with enforcement measures.
Rob earned an LLM from Stanford Law School and is regularly recognized by leading publications like The Legal 500, IAM, and IP Stars, with clients noting that he “combines strong technical skills and a flair for complexity with commercial awareness, pragmatism, and sound judgment.” His clients praise his technical skills, his ability to perform under pressure, and his outstanding leadership in the local community.
-
Sara Burhart
Senior Counsel- Patent LitigationBAT -
Stefanie Kies
Senior Director Intellectual PropertyPolpharma Biologics -
Tamaris Bucher
Principal Patent AttorneyNovartisTamaris is a Principal Patent Attorney at Novartis. She has gained extensive experience in pharmaceuticals in her almost ten years at Novartis, as well as from a previous role at a patent law firm in Basel.
She specialises in patent matters relating to antibody technology and cell & gene therapies. She has expertise in patent prosecution and SPC issues, as well as a keen interest in following legal developments in these areas.
Tamaris is both a registered European Patent Attorney and Swiss Patent Attorney. Additionally, she has a background in Australian patent law, having completed a Master of Industrial Property at the University of Technology, Sydney.
-
Tobias Wuttke
PartnerBardehle Pagenberg